Literature DB >> 18835162

Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents.

Ke-xian Chen1, Hai-ying Xie, Zu-guang Li, Jian-rong Gao.   

Abstract

Predictive quantitative structure-activity relationship analysis was developed for a diverse series of recently synthesized 1-aryl-tetrahydroisoquinoline analogs with anti-HIV activities in this study. The conventional 2D-QSAR models were developed by genetic function approximation (GFA) and stepwise multiple linear regression (MLR) with acceptable explanation of 94.9% and 95.5% and good predicted power of 91.7% and 91.7%, respectively. The results of the 2D-QSAR models were further compared with 3D-QSAR model generated by molecular field analysis (MFA), investigating the substitutional requirements for the favorable receptor-drug interaction and quantitatively indicating the important regions of molecules for their activities. The results obtained by combining these methodologies give insights into the key features for designing more potent analogs against HIV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835162     DOI: 10.1016/j.bmcl.2008.09.056

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  Exploring the structural requirements for jasmonates and related compounds as novel plant growth regulators: a current computational perspective.

Authors:  Ke-Xian Chen; Zu-Guang Li
Journal:  Plant Signal Behav       Date:  2009-11-03

2.  Palladium-catalyzed C(sp(3))-H Arylation of N-Boc benzylalkylamines via a deprotonative cross-coupling process.

Authors:  Nusrah Hussain; Byeong-Seon Kim; Patrick J Walsh
Journal:  Chemistry       Date:  2015-06-30       Impact factor: 5.236

3.  A combined 3D-QSAR and docking studies for the In-silico prediction of HIV-protease inhibitors.

Authors:  Zaheer Ul-Haq; Saman Usmani; Hina Shamshad; Uzma Mahmood; Sobia Ahsan Halim
Journal:  Chem Cent J       Date:  2013-05-17       Impact factor: 4.215

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.